Save the Antibiotic Xenleta as a Last Resort

Xenleta (zen-LEH-tah, lefamulin) will be the first oral and IV med in a new class of "pleuromutilin" antibiotics.

Xenleta is approved for community-acquired pneumonia and covers the common bugs...Strep pneumo, H. flu, and Mycoplasma. It will be touted as an option for resistant infections due to its unique mechanism.

But Xenleta doesn't seem more effective than other antibiotics.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote